Knowledge Center

Article / Feb 01, 2015

The Time Has Come

Authors:
  • Goncalo Andrade
  • Peter Villax
  • Carla Vozone
Source:
PMPS, 2015, February, pp. 30 - 33

The respiratory drug sector is experiencing a surge of interest as companies seek to capitalise on the rapidly growing market.

With new product launches and novel formulation combinations in development, inhaled drug delivery is reaching far beyond its origins in asthma and COPD treatments.

Related links

Also in the Knowledge Center

Related Content

OWN it! Training and Development Needs FY24

Take an active role in your personal development. Follow the new process to identify, plan and own your training and development needs for FY24.

Page
Read more

60 Years

In 2019, ËÄÉ«AV celebrates its 60th Anniversary.

Page
Read more

Inhalation grade particles

ËÄÉ«AV is a global expert in particle engineering, an essential technology when developing inhalation drug products.

Page
Read more